Nuvectis Pharma Inc. (NVCT)
NASDAQ: NVCT
· Real-Time Price · USD
6.09
0.06 (1.00%)
At close: Oct 15, 2025, 3:59 PM
Nuvectis Pharma Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
Revenue | n/a | n/a | 149K | n/a |
Cost of Revenue | n/a | 22.9M | 19.23M | 12.89M |
Gross Profit | n/a | -22.9M | -19.09M | -12.89M |
Operating Income | -19.85M | -22.9M | -19.23M | -12.89M |
Interest Income | 847K | 637K | 149K | 4K |
Pretax Income | -19M | -22.26M | -19.09M | -12.89M |
Net Income | -19M | -22.26M | -18.79M | -12.89M |
Selling & General & Admin | 6.93M | 7.52M | 6.01M | 3.35M |
Research & Development | 12.92M | 15.38M | 13.23M | 9.54M |
Other Expenses | n/a | n/a | n/a | n/a |
Operating Expenses | 19.85M | 22.9M | 19.23M | 12.89M |
Interest Expense | n/a | n/a | 149K | n/a |
Selling & Marketing Expenses | n/a | 14K | n/a | n/a |
Cost & Expenses | 19.85M | 22.9M | 19.23M | 12.89M |
Income Tax Expense | n/a | n/a | -298K | -4K |
Shares Outstanding (Basic) | 17.11M | 15.56M | 12.66M | 12.72M |
Shares Outstanding (Diluted) | 17.11M | 15.56M | 12.66M | 12.72M |
EPS (Basic) | -1.11 | -1.43 | -1.48 | -1.01 |
EPS (Diluted) | -1.11 | -1.43 | -1.48 | -1.01 |
EBITDA | -19M | -22.9M | -19.23M | -12.89M |
EBIT | -19M | -21.9M | -19.09M | -12.89M |
Depreciation & Amortization | n/a | -1M | -1.2M | -7.1M |
Source: Financial Modeling Prep. Financial Sources.